Summary & Overview
HCPCS Level II C9151: Injection, pegcetacoplan, 1 mg
HCPCS Level II code C9151 denotes the administration unit for pegcetacoplan, recorded as “Injection, pegcetacoplan, 1 mg.” This code is significant nationally as pegcetacoplan represents an intravitreal pharmacologic therapy used in treating complement-mediated retinal diseases; accurate coding affects claims processing, clinical tracking, and payer coverage decisions. Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose and typical sites of service, plus national benchmarking context where available. The publication summarizes how C9151 is used on service lines, common modifiers and billing considerations, associated clinical indications and related coding, and payer-specific coverage patterns when present. It will also highlight policy updates, reimbursement benchmarks, and coding guidance relevant to revenue cycle and compliance teams. Data not available in the input is noted where applicable; the focus remains on standardized interpretation of HCPCS Level II code C9151 and its relevance for billing, clinical coding, and payer negotiations.
Billing Code Overview
HCPCS Level II code C9151 represents Injection, pegcetacoplan, 1 mg. This service describes administration of a targeted complement C3 inhibitor formulated for intravitreal injection to treat retinal conditions where pegcetacoplan is indicated.
-
Service type: Drug administration, intravitreal injection
-
Typical site of service: Ambulatory ophthalmology clinic or outpatient surgical/ procedural setting
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with paroxysmal nocturnal hemoglobinuria (PNH) or geographic atrophy related to age-related macular degeneration who requires parenteral complement inhibition with pegcetacoplan. The encounter occurs in an outpatient infusion center, ophthalmology clinic procedure room, or specialty injection suite. Prior to administration, the clinician confirms indication, documents prior therapies and vaccinations per label (for PNH), reviews allergies, obtains informed consent, and assesses vital signs. The drug C9151 is billed per milligram, so the pharmacy prepares the calculated dose in a sterile compounding area and delivers it to the administering clinician. The clinician or trained nurse performs the intravitreal injection (for ophthalmic use) or subcutaneous/IV infusion as indicated by the product formulation and diagnosis, monitors the patient for immediate adverse reactions for the recommended observation period, documents lot number and expiration, and provides post-procedure instructions. Billing captures the HCPCS Level II code C9151 with appropriate modifier(s) for services such as outpatient hospital (modifier AS) or professional/technical distinctions when applicable. Documentation includes indication, dose administered (mg), route, site, consent, lot number, and any immediate reactions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|